Literature DB >> 9674708

Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions.

P Karnik1, P Chen, M Paris, H Yeger, B R Williams.   

Abstract

Loss of heterozygosity (LOH) on the short arm of chromosome 11 is the most frequent genetic alteration in Wilms tumors, indicating that one or more tumor suppressor genes that map to this chromosomal region are involved in the development of the disease. The WT1 gene located on 11p13 has been characterized but mutations in this gene occur in only about 10% of Wilms tumors. A second locus (WT2) at chromosome 11p15 has also been described in Wilms tumors but thus far efforts to clone the WT2 gene(s) have been frustrated by the large size (approximately 10 Mb) of this region. Using a high-density marker LOH analysis of 11p15.5-15.4, we have refined the location of a Wilms tumor suppressor gene between the markers D11S1318-D11S1288 (approximately 800 kb) within 11p15.5. We have also identified a second, novel region of LOH that spans the markers D11S1338-D11S1323 (approximately 336 kb) at 11p15.5-p115.4. Thus a second distinct locus, in addition to the previously defined WT2, on chromosome 11p15.5, appears to play a role in the development of Wilms tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674708     DOI: 10.1038/sj.onc.1201959

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  A nucleolar protein, H19 opposite tumor suppressor (HOTS), is a tumor growth inhibitor encoded by a human imprinted H19 antisense transcript.

Authors:  Patrick Onyango; Andrew P Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-21       Impact factor: 11.205

2.  Genetic clonality is a feature unifying nephroblastomas regardless of the variety of morphological subtypes.

Authors:  Barbara Guertl; Ivo Leuschner; Dieter Harms; Gerald Hoefler
Journal:  Virchows Arch       Date:  2006-05-20       Impact factor: 4.064

Review 3.  Cancer and forensic microsatellites.

Authors:  Karen Page; Eleanor A M Graham
Journal:  Forensic Sci Med Pathol       Date:  2008-02-02       Impact factor: 2.007

4.  Shared Copy Number Variation in Simultaneous Nephroblastoma and Neuroblastoma due to Fanconi Anemia.

Authors:  A Serra; K Eirich; A K Winkler; K Mrasek; G Göhring; G Barbi; H Cario; B Schlegelberger; B Pokora; T Liehr; C Leriche; D Henne-Bruns; T F Barth; D Schindler
Journal:  Mol Syndromol       Date:  2012-08-23

5.  Decreased expression of p57(KIP2)mRNA in human bladder cancer.

Authors:  M Oya; W A Schulz
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

6.  The serine/threonine kinase 33 is present and expressed in palaeognath birds but has become a unitary pseudogene in neognaths about 100 million years ago.

Authors:  Tobias Lautwein; Steffen Lerch; Daniel Schäfer; Erwin R Schmidt
Journal:  BMC Genomics       Date:  2015-07-22       Impact factor: 3.969

Review 7.  Contributions of integrin-linked kinase to breast cancer metastasis and tumourigenesis.

Authors:  Cimona V Hinton; Shalom Avraham; Hava Karsenty Avraham
Journal:  J Cell Mol Med       Date:  2008-03-19       Impact factor: 5.310

8.  STK33 alleviates gentamicin-induced ototoxicity in cochlear hair cells and House Ear Institute-Organ of Corti 1 cells.

Authors:  Meijuan Zhou; Gaoying Sun; Lili Zhang; Guodong Zhang; Qianqian Yang; Haiyan Yin; Hongrui Li; Wenwen Liu; Xiaohui Bai; Jianfeng Li; Haibo Wang
Journal:  J Cell Mol Med       Date:  2018-09-06       Impact factor: 5.310

Review 9.  Genetic Predisposition to Solid Pediatric Cancers.

Authors:  Mario Capasso; Annalaura Montella; Matilde Tirelli; Teresa Maiorino; Sueva Cantalupo; Achille Iolascon
Journal:  Front Oncol       Date:  2020-10-28       Impact factor: 6.244

10.  Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.

Authors:  Gaojianyong Wang; Dimitris Anastassiou
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.